Complement-induced retinal arteriolar occlusions in the cat

被引:13
作者
Lai, JC [1 ]
Johnson, MW [1 ]
Martonyi, CL [1 ]
Till, GO [1 ]
机构
[1] UNIV MICHIGAN, SCH MED, WK KELLOGG EYE CTR, DEPT OPHTHALMOL, ANN ARBOR, MI USA
来源
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES | 1997年 / 17卷 / 03期
关键词
cobra venom factor; complement; granulocyte; leukoembolization; Purtscher's retinopathy; retinal arteriolar occlusion;
D O I
10.1097/00006982-199705000-00011
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To develop an animal model of complement-induced retinal vasculopathy and determine whether it resembles Purtscher's retinopathy. Methods: Intravenous cobra venom factor was used to achieve intravascular activation of the complement system in cats. After a single bolus of cobra venom factor (75 units/kg), retinal blood flow was monitored at regular intervals by fluorescein angioscopy and angiography. Results: Multiple small retinal arteriolar occlusions were present during the initial fluorescein transit of the immediate postinjection fluorescein study in 12 of 12 animals. Small, rapidly moving gaps in the fluorescein column were seen in two thirds of the animals observed continuously by fluorescein angioscopy. Angiographically, the obstructions were transient, and filling of the associated patches of capillary nonperfusion occurred within 3 minutes. Purtscher's-like ischemic retinal infarcts did not develop in any eye, Histopathologic analysis failed to demonstrate the nature of the transient vascular obstructive lesions, but indirect evidence suggested the possibility of granulocyte aggregates. Conclusion: Intravascular activation of the complement system produces transient microembolic retinal arteriolar occlusions in the cat. Although this model may represent a mild form of Purtscher's retinopathy, factors in addition to complement activation appear necessary to induce ischemic retinal infarcts.
引用
收藏
页码:239 / 246
页数:8
相关论文
共 36 条
[1]  
ABRAMSON S, 1987, J RHEUMATOL, V14, P43
[2]   PATHOGENESIS OF PURTSCHER RETINOPATHY - AN EXPERIMENTAL-STUDY [J].
BEHRENSBAUMANN, W ;
SCHEURER, G ;
SCHROER, H .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 1992, 230 (03) :286-291
[3]   M-PURTSCHER - RANGE OF CLINICAL MANIFESTATIONS AND PATHOGENESIS [J].
BEHRENSBAUMANN, W ;
SCHEURER, G .
KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 1991, 198 (02) :99-107
[4]  
BLODI BA, 1990, OPHTHALMOLOGY, V97, P1654
[5]  
BURTON TC, 1980, OPHTHALMOLOGY, V87, P1096
[6]  
CHANG M, 1984, OPHTHALMOLOGY, V91, P1634
[7]   HEMODIALYSIS LEUKOPENIA - PULMONARY VASCULAR LEUKOSTASIS RESULTING FROM COMPLEMENT ACTIVATION BY DIALYZER CELLOPHANE MEMBRANES [J].
CRADDOCK, PR ;
FEHR, J ;
DALMASSO, AP ;
BRIGHAM, KL ;
JACOB, HS .
JOURNAL OF CLINICAL INVESTIGATION, 1977, 59 (05) :879-888
[8]   COMPLEMENT (C5A)-INDUCED GRANULOCYTE AGGREGATION INVITRO - POSSIBLE MECHANISM OF COMPLEMENT-MEDIATED LEUKOSTASIS AND LEUKOPENIA [J].
CRADDOCK, PR ;
HAMMERSCHMIDT, D ;
WHITE, JG ;
DALMASSO, AP ;
JACOB, HS .
JOURNAL OF CLINICAL INVESTIGATION, 1977, 60 (01) :260-264
[9]   INSTABILITY OF LEUKOCYTE AGGREGATION - LACK OF EVIDENCE FOR LEUKOEMBOLIZATION DURING VARIOUS STATES OF INFLAMMATION [J].
FADILAH, R ;
BERLINER, S ;
YULI, I ;
WEINBERGER, D ;
NILI, M ;
BENBASSAT, M ;
STERNBERG, E ;
PINKHAS, J ;
ARONSON, M .
INFLAMMATION, 1988, 12 (05) :425-432
[10]  
GASS JDM, 1987, STEREOSCOPIC ATLAS M, V2, P558